Receptos, Inc.
Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY14 | FY13 | FY12 | |
|---|---|---|---|
| Revenue | — | — | — |
| Operating income | −$111.6M | −$47.9M | −$17.7M |
| Net income | −$115.0M | −$48.3M | −$17.7M |
| Total assets | $678.0M | $71.2M | $6.9M |
| Total liabilities | $28.5M | $20.4M | $7.1M |
| Equity | $649.5M | $50.8M | −$40.0M |
| EPS (diluted) | — | — | — |
| Shares out. | 22.2M | 18.4M | 2.4M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2014- Operating margin
- —
- Net margin
- —
- Return on equity
- −17.7%
- Return on assets
- −17.0%
- Return on capital (ROCE)
- −17.2%
- Liabilities / assets
- 4.2%
- Debt / equity
- 0.04×
- Book value / share
- $29.30
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2014- Altman Z″ (distress)
- 28.05safe
- Accruals / assets
- −3.4%clean
- Piotroski F-Score
- 4/7mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 warning● 3 good- Negative operating cash flow
- Conservative leverage (liabilities < 50% of assets)
- Clean earnings (low accruals)
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Material events
SEC Form 8-K · most recent- Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylawsAug 27, 2015
- Entered a material agreement · Director / officer changeJul 16, 2015
- Other material eventJul 14, 2015
- Shareholder voteJun 1, 2015
- Results of operationsMay 5, 2015
- Regulation FD disclosure · Other material eventApr 16, 2015
- Results of operationsMar 3, 2015
- Regulation FD disclosureFeb 23, 2015
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SC 13G/AFeb 12, 2016
- SC 13G/ASep 10, 2015
- 15-12BFORM 15-12BSep 8, 2015
- EFFECTAug 28, 2015
- 4FORM 4 SUBMISSIONAug 27, 2015
- 4FORM 4 SUBMISSIONAug 27, 2015
- 4FORM 4 SUBMISSIONAug 27, 2015
- 4FORM 4 SUBMISSIONAug 27, 2015
- 4FORM 4 SUBMISSIONAug 27, 2015
- 4FORM 4 SUBMISSIONAug 27, 2015
- 4FORM 4 SUBMISSIONAug 27, 2015
- 4FORM 4 SUBMISSIONAug 27, 2015
- 4FORM 4 SUBMISSIONAug 27, 2015
- 4FORM 4 SUBMISSIONAug 27, 2015
- 4FORM 4 SUBMISSIONAug 27, 2015
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.